- Atlas
- Medicine & Health
- Clinical Pharmacy
Clinical Pharmacy
For most of the history of pharmacy, the pharmacist's job was defined by the product: compounding a mixture, weighing a powder, rolling a pill, and handing over a bottle with instructions.
8 frameworks, from 1960 to today · Pharmacy · Medicine & Health
- Clinical Pharmacy Movement 1960-Present
- Clinical Pharmacokinetics 1970-Present
- Therapeutic Drug Monitoring 1975-Present
- Pharmaceutical Care 1990-Present
- Medication Safety and Systems Thinking 1991-Present
- Antimicrobial Stewardship 1995-Present
- Evidence-Based Clinical Pharmacy 1995-Present
- Deprescribing 2008-Present
Overview
For most of the history of pharmacy, the pharmacist's job was defined by the product: compounding a mixture, weighing a powder, rolling a pill, and handing over a bottle with instructions. The prescriber made the decision; the pharmacist executed it. Clinical pharmacy is the movement that changed this. It redefined the pharmacist as a professional whose primary concern is the patient and the outcome of drug therapy, not merely the accurate preparation and delivery of a product. A clinical pharmacist reviews a patient's full medication regimen, asks whether each drug is indicated, dosed correctly for that person's kidneys and liver, and whether it interacts dangerously with the rest. The field's central insight is that most medication problems are not manufacturing failures but decisions—wrong drug, wrong dose, wrong duration—and that someone with pharmacological training needs to be present where those decisions get made.
The Mid-Century Hospital as the Cradle
Clinical pharmacy emerged in the United States in the 1950s and 1960s, first inside hospitals. Before then, hospital pharmacists mostly managed inventories and manufactured bulk preparations in the basement pharmacy. The rise of manufactured drugs after the Second World War—antibiotics, antihypertensives, corticosteroids—meant that hospitals no longer needed to compound much, and the pharmacist's traditional skills risked becoming marginal. At the same time, the number of drugs available exploded, drug interactions became a real clinical concern, and prescribing errors in hospitals were increasingly visible.
A key institutional step was the creation of hospital pharmacy residency programmes and the founding of the American Society of Hospital Pharmacists (1942), which later pushed for the pharmacist's clinical role. In the 1960s a few hospital pharmacists began attending ward rounds alongside physicians, offering drug information at the point of prescribing. The University of Kentucky and the University of California, San Francisco, were among the early sites where such "clinical" roles were formalised in the 1960s and 1970s. The term clinical pharmacy was in use by the mid-1960s to mark this shift from product to patient.
The Clinical Pharmacy Movement and Pharmaceutical Care
The movement needed a philosophy. In 1975, the Millis Commission report, sponsored by the American Association of Colleges of Pharmacy, argued that pharmacy education should train pharmacists as clinicians and that the profession should orient itself toward patient care. Pharmacy schools responded by adding clinical coursework, patient-contact rotations, and eventually the Doctor of Pharmacy (PharmD) as the entry degree in the United States, replacing the bachelor's-level BSc in Pharmacy by the early 2000s.
The defining theoretical statement came in 1990, when Charles Hepler and Linda Strand published "Opportunities and Responsibilities in Pharmaceutical Care."1 Their concept, pharmaceutical care, declared that the practitioner's responsibility is to ensure that drug therapy achieves defined therapeutic goals that improve a patient's quality of life, and that the pharmacist shares accountability for that outcome1. The idea is deceptively simple but radical: it makes the pharmacist responsible for results, not just for accuracy at the counter. The American Society of Health-System Pharmacists adopted the concept in 1993, and pharmaceutical care became the profession's guiding language worldwide. Between 1995 and 2000 the International Pharmaceutical Federation (FIP) promoted it globally, and in 1997 a group of European pharmacy organisations issued the Granada statement on the pharmacist's role in health care.
Clinical Pharmacokinetics and Therapeutic Drug Monitoring
To be trusted with dosing, pharmacists needed a quantitative science of the body's handling of drugs—clinical pharmacokinetics: the study of how a drug is absorbed, distributed, metabolised, and eliminated in patients2. The four parameters at its core are clearance (the volume of blood cleared of drug per unit time), volume of distribution (the apparent space the drug occupies), half-life (the time for blood concentration to halve), and bioavailability (the fraction of a dose reaching the bloodstream intact). These made it possible to predict how a dose should change when a patient's kidney function fails or when another drug speeds or slows metabolism.
Therapeutic drug monitoring (TDM) is the practical companion: measuring drug concentrations in blood at defined times and adjusting the dose to keep the patient within a therapeutic window3. It matters most for drugs where the gap between helpful and harmful is narrow—digoxin, phenytoin, lithium, the aminoglycoside antibiotics, and later the immunosuppressants cyclosporine and tacrolimus, and the antiepileptic vancomycin's counterpart gentamicin. Formal pharmacokinetic consult services staffed by pharmacists appeared in the 1970s and 1980s; Bayesian dose-prediction software that combines population data with a patient's measured levels arrived later and improved individualisation.
From Error Counting to Medication Safety
Parallel to this came medication safety: the study and prevention of medication errors and adverse drug events. The field's landmark study was published in 1991 by Lucian Leape and colleagues—the Harvard Medical Practice Study analysis of medication errors in two Boston hospitals—which documented that adverse drug events were common and that most arose from errors in prescribing and administration rather than in dispensing. Earlier, in 1961, the UK's British Medical Journal case series by E. A. Barker and colleagues and the work of others had started to count errors systematically, but it was the 1990s that turned this into a discipline.
Two ideas reshaped the field. One was high-alert medications—drug classes such as anticoagulants, insulin, opioids, and concentrated electrolytes that cause disproportionate harm when misused, and which require special handling. The other was systems thinking: that errors are usually caused by faulty processes, not careless individuals, a view made famous by the Institute of Medicine's 1999 report To Err Is Human. Pharmacists became central to safety reforms—medication reconciliation at admission and discharge, standardised hospital order sets, unit-dose packaging, computerised prescriber order entry with clinical decision support, and the Swiss cheese model of layered defences. Today no hospital pharmacy department is without a drug use safety programme.
The Hospital Ward Reaches Out: Clinical Practice and Evidence
By the 1990s and 2000s clinical pharmacy had expanded beyond the hospital pharmacy and into specialty roles. Ward-based clinical pharmacists, critical care pharmacists, oncology and transplant pharmacists, and ambulatory clinic pharmacists became common. The pharmacist's tools shifted toward evidence-based clinical pharmacy: querying the primary literature and systematic reviews to answer bedside drug questions, and applying tools like the Cochrane Library and formal evidence grading (e.g. GRADE) to prescribing decisions. Pharmacy-based literature evaluation became a taught skill, and formulary management—deciding which agents a hospital or health system stocks and how—became a clinical responsibility with economic stakes.
Antimicrobial stewardship is the clearest example of a distinctive clinical pharmacy practice4. The rise of antibiotic resistance, recognised with force in the 1990s, pushed hospitals to create stewardship teams to monitor prescribing, restrict broad-spectrum agents, de-escalate therapy based on culture results, and link the right drug and dose to the right duration. Pharmacists lead many of these programmes today. The shift from "the pharmacist dispenses" to "the pharmacist guides therapy" is nowhere more visible than here.
Deprescribing and the Current Frontier
The newest turn is deprescribing: the deliberate, supervised withdrawal of medicines that are no longer appropriate5. It arrived with the ageing of populations and the recognition that many older patients are on long lists of drugs—polypharmacy—that accumulate over years and produce harm through interactions and adverse effects. Related movements in geriatric medicine (the Beers Criteria, first published in 1991, and the STOPP/START criteria from Ireland, 2008) gave clinicians explicit lists of inappropriate medications for older people. Deprescribing asks not simply whether a drug is appropriate but whether its indication still exists, whether its benefit now outweighs its burden, and what tapering is safe5. It is a natural extension of pharmaceutical care: if the pharmacist is accountable for outcomes, that must include the outcome of stopping.
References
- Pharmaceutical care (History), Wikipedia
- Pharmacokinetics, Wikipedia
- Therapeutic drug monitoring, Wikipedia
- Antimicrobial stewardship, Wikipedia
- Deprescribing, Wikipedia
The frameworks of Clinical Pharmacy
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1960-Present
Clinical Pharmacy Movement
Should the pharmacist focus on the patient rather than the product?
- 1970-Present
- 1975-Present
Therapeutic Drug Monitoring
How should a dose be adjusted to a measured drug level?
- 1990-Present
- 1991-Present
Medication Safety and Systems Thinking
Why do medication errors happen and how can they be prevented?
- 1995-Present
Antimicrobial Stewardship
How should antibiotic use be guided to preserve their power?
- 1995-Present
Evidence-Based Clinical Pharmacy
How should evidence be used to answer a bedside drug question?
- 2008-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Clinical Pharmacokinetics grew out of Clinical Pharmacy Movement
The clinical pharmacy movement's push for pharmacists to take responsibility for drug therapy created the demand for a quantitative science of dosing. Pharmacist-run pharmacokinetic consult services emerged in the 1970s as a direct clinical arm of that movement.
Carried by American Society of Hospital Pharmacists; University of Kentucky.
Pharmaceutical Care grew out of Clinical Pharmacy Movement
Hepler and Strand's 1990 pharmaceutical care concept was the defining theoretical statement of the clinical pharmacy movement, making explicit the pharmacist's accountability for patient outcomes that the movement had been building toward since the 1960s.
Carried by Charles Hepler; Linda Strand; Opportunities and Responsibilities in Pharmaceutical Care (1990).
Therapeutic Drug Monitoring grew out of Clinical Pharmacokinetics
Therapeutic drug monitoring grew directly out of clinical pharmacokinetics: measuring blood concentrations and applying clearance, volume of distribution and half-life to individualise doses. TDM is the practical application of pharmacokinetic parameters at the bedside.
Deprescribing grew out of Pharmaceutical Care
Deprescribing extends pharmaceutical care's accountability for outcomes to the decision to stop drugs: if the pharmacist is responsible for therapeutic results, that must include the outcome of withdrawal. The concept is framed explicitly as a natural extension of Hepler and Strand's idea.
Medication Safety and Systems Thinking influenced by Clinical Pharmacy Movement
The clinical pharmacy movement's presence on hospital wards made prescribing and administration errors visible to pharmacists, who then built the medication safety discipline. Leape's 1991 study and the systems-thinking reforms that followed were carried largely by hospital pharmacists.
Carried by Lucian Leape.
Antimicrobial Stewardship grew out of Clinical Pharmacy Movement
Antimicrobial stewardship is a branch of clinical pharmacy practice: ward pharmacists monitoring and guiding antibiotic prescribing applied the movement's core method to antibiotics. Pharmacists lead most stewardship programmes today.
Evidence-Based Clinical Pharmacy grew out of Clinical Pharmacy Movement
Evidence-based clinical pharmacy grew out of the clinical pharmacy movement's ward-based drug information role, adding formal literature evaluation and evidence grading to the pharmacist's bedside toolkit.
Deprescribing influenced by Medication Safety and Systems Thinking
Medication safety's focus on adverse drug events in polypharmacy, and the Beers Criteria (1991) that grew from that concern, supplied the harm evidence and inappropriate-medication lists that deprescribing built on.
Carried by Beers Criteria (1991).
Beyond the field
Where Clinical Pharmacy's ideas came from in other fields, and what they led to there: the strongest 12 of 49 links.
Clinical Pharmacy Movement led to Pharmaceutical care in Pharmacy
Pharmaceutical care grew directly out of the clinical pharmacy movement, extending its patient-oriented practice into an explicit philosophy of responsibility for drug-related outcomes, as set out by Hepler and Strand in 1990.
Carried by Charles D. Hepler; Linda M. Strand.
Clinical Pharmacy Movement led to Pharmaceutical Care in Social And Administrative Pharmacy
Pharmaceutical care is the direct successor of the clinical pharmacy movement, taking its patient-oriented practice and making pharmacist accountability for outcomes its organising principle. The movement's leaders formulated pharmaceutical care.
Carried by Hepler and Strand, Opportunities and Responsibilities in Pharmaceutical Care (1990).
Clinical Pharmacokinetics grew out of Pharmacokinetics in Pharmacology
This duplicate pharmacokinetics entry is the same parent science from which clinical pharmacokinetics branched; the later specialty applied its models to dosing individual patients.
Clinical Pharmacokinetics grew out of Pharmacokinetics in Pharmacology
Clinical pharmacokinetics is a direct application and branch of the pharmacokinetic science that developed from the 1930s onward, taking its compartmental and clearance models into patient care.
Clinical Pharmacokinetics grew out of Pharmacokinetics in Translational Pharmacology
Clinical pharmacokinetics is the translational application of the pharmacokinetic science filed here, carrying its concepts into bedside dose individualization from the 1970s.
Clinical Pharmacokinetics grew out of Pharmacokinetics in Clinical Pharmacology
Clinical pharmacokinetics grew directly out of pharmacokinetics as a general pharmacological science, applying its compartment models and clearance concepts to individual patients; the journal Clinical Pharmacokinetics was founded in 1976 as the specialty's organ.
Carried by Clinical Pharmacokinetics (1976).
Pharmaceutical Care grew out of Clinical Pharmacy in Pharmacy Practice
Pharmaceutical care is the direct refinement of the clinical pharmacy movement, generalizing its patient-care focus into a stated professional covenant.
Carried by Charles D. Hepler; Linda M. Strand.
Pharmaceutical Care grew out of Clinical pharmacy in Pharmacy
Pharmaceutical care grew directly out of clinical pharmacy, extending its patient-oriented practice to an explicit philosophy of responsibility for drug-related outcomes, as set out by Hepler and Strand in 1990.
Carried by Charles D. Hepler; Linda M. Strand.
Medication Safety and Systems Thinking influenced by Human Error and Latent Conditions Model in Patient Safety
Reason's human error and latent conditions model, published in the late 1980s and early 1990s, was taken up by medication safety researchers as the core explanatory framework for systems failures in drug therapy.
Carried by James Reason.
Clinical Pharmacy Movement influenced Social Pharmacy in Social And Administrative Pharmacy
The clinical pharmacy movement of the 1960s provided the professional reform impulse from which social pharmacy branched, extending the movement's patient focus to the social and behavioural determinants of medicine use.
Clinical Pharmacy Movement led to Pharmaceutical Care in Pharmacy Practice
The clinical pharmacy movement was the professional base from which pharmaceutical care was proposed, and pharmaceutical care was offered as a refinement of its mission rather than a break.
Carried by Charles D. Hepler; Linda M. Strand.
Clinical Pharmacy Movement reacted against Dispensing and Prescription-Fulfilment Model in Pharmacy Practice
The clinical pharmacy movement defined itself against the dispensing and prescription-fulfilment model, arguing that pharmacists should take responsibility for drug therapy outcomes rather than merely compounding and dispensing products.
Carried by Donald C. Francke.

Clinical Pharmacy is a planet in Nousfarer
Its city has a tower for each of these 8 frameworks. Land, walk in, and climb one concept at a time.
Land on Clinical PharmacyRelated fields
Fields its ideas are linked to
- Pharmacy Practice 12 links
- Pharmacology 7 links
- Social And Administrative Pharmacy 7 links
- Pharmacy 5 links
- Translational Pharmacology 4 links
- Patient Safety 3 links
- Clinical Pharmacology 2 links
- Pharmacometrics 2 links
- Geriatric Medicine 1 link
- Clinical Decision Science 1 link
- Pharmacodynamics 1 link
- Pharmacokinetics 1 link
More in Pharmacy
- Pharmaceutical Chemistry
- Pharmaceutics
- Pharmacognosy
- Pharmacy
- Pharmacy Practice
- Social And Administrative Pharmacy
See where Clinical Pharmacy sits on the Map of Human Knowledge